Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Xiang LiNational Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Key Laboratory of Modern Preparation of TCM, Ministry of Education, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID 0000-0003-1526-6103
Xiangping WuNational Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Key Laboratory of Modern Preparation of TCM, Ministry of Education, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Weiqiang SuNational Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Key Laboratory of Modern Preparation of TCM, Ministry of Education, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Nina FilipczakCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.ORCID 0000-0001-9285-8298
Satya Siva Kishan YalamartyCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.
Wenhao JiangNational Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Key Laboratory of Modern Preparation of TCM, Ministry of Education, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID 0009-0006-9256-8710
Dongyun TaoNational Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Key Laboratory of Modern Preparation of TCM, Ministry of Education, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Shiyun YangNational Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Key Laboratory of Modern Preparation of TCM, Ministry of Education, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Jing ZhangNational Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Key Laboratory of Modern Preparation of TCM, Ministry of Education, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID 0000-0002-6313-5741
Funding
the Jiangxi Provincial Department of Education GJJ2400823
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
breast cancercalcium/aluminum coresPAMAMPD-L1 siRNAziyuglycoside II
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Calcium/Aluminum-Cored Asymmetric Bilayer Nanoparticles for Codelivery of Ziyuglycoside II and PD-L1 siRNA Exert Anti-Breast Tumor Effects. · full record | OpenQuestion